About The Clinical Edge

I write about healthcare microcaps.

Most investors avoid small healthcare companies because they're volatile and complex.

Clinical trials fail. Cash burns quickly. Share prices can drop 50% overnight.

But I believe this volatility creates opportunity.

When the market misunderstands clinical data or overreacts to temporary setbacks, real mispricings emerge.

Every month, I share 2-3 healthcare microcap opportunities which I believe have high asymmetric potential - companies with multiple shots on goal, aligned management, and mispriced optionality.

Subscribe if that sounds like something you would be interested in.

Disclaimer: The content provided in this newsletter is for informational purposes only and does not constitute financial, investment, or other professional advice. The opinions expressed here are those of the author and do not necessarily reflect the views of Schwar Capital. Investing involves risk, including the possible loss of principal. Past performance is not indicative of future results. The author may or may not hold positions in the stocks or other financial instruments mentioned. Always do your own research or consult with a qualified financial advisor before making any investment decisions. To read our full disclaimer, click here.